vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Texas Community Bancshares, Inc. (TCBS). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $4.4M, roughly 1.8× Texas Community Bancshares, Inc.). Texas Community Bancshares, Inc. runs the higher net margin — 18.9% vs -48.7%, a 67.6% gap on every dollar of revenue. On growth, Texas Community Bancshares, Inc. posted the faster year-over-year revenue change (10.8% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $973.0K). Over the past eight quarters, Texas Community Bancshares, Inc.'s revenue compounded faster (22.5% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Huntington Bancshares Incorporated is an American bank holding company headquartered in Columbus, Ohio. Its banking subsidiary, The Huntington National Bank, operates 1,047 banking offices, primarily in the Midwest: 459 in Ohio, 290 in Michigan, 80 in Minnesota, 51 in Pennsylvania, 45 in Indiana, 35 in Illinois, 32 in Colorado, 29 in West Virginia, 16 in Wisconsin, 10 in Kentucky, and one in North Carolina.

CCEL vs TCBS — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.8× larger
CCEL
$7.8M
$4.4M
TCBS
Growing faster (revenue YoY)
TCBS
TCBS
+13.0% gap
TCBS
10.8%
-2.3%
CCEL
Higher net margin
TCBS
TCBS
67.6% more per $
TCBS
18.9%
-48.7%
CCEL
More free cash flow
CCEL
CCEL
$240.6K more FCF
CCEL
$1.2M
$973.0K
TCBS
Faster 2-yr revenue CAGR
TCBS
TCBS
Annualised
TCBS
22.5%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
TCBS
TCBS
Revenue
$7.8M
$4.4M
Net Profit
$-3.8M
$841.0K
Gross Margin
77.9%
Operating Margin
-50.6%
23.1%
Net Margin
-48.7%
18.9%
Revenue YoY
-2.3%
10.8%
Net Profit YoY
-105.1%
62.7%
EPS (diluted)
$-0.46
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
TCBS
TCBS
Q4 25
$7.8M
$4.4M
Q3 25
$7.8M
$4.4M
Q2 25
$7.9M
$3.8M
Q1 25
$8.0M
$3.8M
Q4 24
$8.0M
$3.2M
Q3 24
$8.1M
$3.7M
Q2 24
$8.0M
$3.6M
Q1 24
$7.9M
$3.0M
Net Profit
CCEL
CCEL
TCBS
TCBS
Q4 25
$-3.8M
$841.0K
Q3 25
$749.4K
$680.0K
Q2 25
$355.8K
$678.0K
Q1 25
$282.9K
$643.0K
Q4 24
$-1.9M
$517.0K
Q3 24
$1.1M
$515.0K
Q2 24
$655.8K
$348.0K
Q1 24
$556.2K
$-2.7M
Gross Margin
CCEL
CCEL
TCBS
TCBS
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
TCBS
TCBS
Q4 25
-50.6%
23.1%
Q3 25
24.3%
17.4%
Q2 25
18.8%
21.9%
Q1 25
13.3%
19.8%
Q4 24
-1.5%
19.1%
Q3 24
17.2%
16.1%
Q2 24
17.3%
11.1%
Q1 24
10.5%
-114.5%
Net Margin
CCEL
CCEL
TCBS
TCBS
Q4 25
-48.7%
18.9%
Q3 25
9.6%
15.4%
Q2 25
4.5%
18.1%
Q1 25
3.5%
17.0%
Q4 24
-23.2%
16.2%
Q3 24
13.0%
13.8%
Q2 24
8.2%
9.7%
Q1 24
7.1%
-90.6%
EPS (diluted)
CCEL
CCEL
TCBS
TCBS
Q4 25
$-0.46
$0.31
Q3 25
$0.09
$0.24
Q2 25
$0.04
$0.23
Q1 25
$0.03
$0.22
Q4 24
$-0.23
$0.16
Q3 24
$0.13
$0.17
Q2 24
$0.08
$0.12
Q1 24
$0.07
$-0.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
TCBS
TCBS
Cash + ST InvestmentsLiquidity on hand
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$53.8M
Total Assets
$61.7M
$429.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
TCBS
TCBS
Q4 25
$3.3M
Q3 25
$3.2M
Q2 25
$4.4M
Q1 25
$3.5M
Q4 24
$3.5M
Q3 24
$2.1M
Q2 24
$1.5M
Q1 24
$979.6K
Total Debt
CCEL
CCEL
TCBS
TCBS
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
TCBS
TCBS
Q4 25
$-18.6M
$53.8M
Q3 25
$-14.8M
$53.5M
Q2 25
$-15.6M
$52.9M
Q1 25
$-14.7M
$52.8M
Q4 24
$-13.2M
$52.1M
Q3 24
$-9.6M
$52.7M
Q2 24
$-10.7M
$51.8M
Q1 24
$-10.3M
$51.5M
Total Assets
CCEL
CCEL
TCBS
TCBS
Q4 25
$61.7M
$429.8M
Q3 25
$63.2M
$439.5M
Q2 25
$64.4M
$444.1M
Q1 25
$64.4M
$442.2M
Q4 24
$64.7M
$443.5M
Q3 24
$62.9M
$446.0M
Q2 24
$62.6M
$451.6M
Q1 24
$61.7M
$463.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
TCBS
TCBS
Operating Cash FlowLast quarter
$1.3M
$1.4M
Free Cash FlowOCF − Capex
$1.2M
$973.0K
FCF MarginFCF / Revenue
15.5%
21.9%
Capex IntensityCapex / Revenue
0.9%
8.9%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$1.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
TCBS
TCBS
Q4 25
$1.3M
$1.4M
Q3 25
$2.5M
$1.6M
Q2 25
$707.0K
$1.0M
Q1 25
$954.1K
$-1.5M
Q4 24
$2.2M
$1.9M
Q3 24
$2.4M
$816.0K
Q2 24
$1.8M
$404.0K
Q1 24
$-356.9K
$641.0K
Free Cash Flow
CCEL
CCEL
TCBS
TCBS
Q4 25
$1.2M
$973.0K
Q3 25
$2.5M
$1.6M
Q2 25
$644.6K
$822.0K
Q1 25
$892.0K
$-1.6M
Q4 24
$2.1M
$740.0K
Q3 24
$2.3M
$805.0K
Q2 24
$21.5K
$209.0K
Q1 24
$-814.6K
$-345.0K
FCF Margin
CCEL
CCEL
TCBS
TCBS
Q4 25
15.5%
21.9%
Q3 25
31.9%
35.2%
Q2 25
8.1%
21.9%
Q1 25
11.2%
-41.2%
Q4 24
26.8%
23.2%
Q3 24
27.9%
21.5%
Q2 24
0.3%
5.8%
Q1 24
-10.4%
-11.6%
Capex Intensity
CCEL
CCEL
TCBS
TCBS
Q4 25
0.9%
8.9%
Q3 25
0.5%
0.9%
Q2 25
0.8%
4.9%
Q1 25
0.8%
0.7%
Q4 24
0.1%
37.6%
Q3 24
2.3%
0.3%
Q2 24
21.8%
5.5%
Q1 24
5.8%
33.3%
Cash Conversion
CCEL
CCEL
TCBS
TCBS
Q4 25
1.63×
Q3 25
3.38×
2.34×
Q2 25
1.99×
1.49×
Q1 25
3.37×
-2.38×
Q4 24
3.75×
Q3 24
2.32×
1.58×
Q2 24
2.70×
1.16×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons